Oncolytic adenovirus decreases the proportion of TIM-3(+) subset of tumor-infiltrating CD8(+) T cells with correlation to improved survival in patients with cancer

Ilkka Liikanen, Saru Basnet, Dafne C. A. Quixabeira, Kristian Taipale, Otto Hemminki, Minna Oksanen, Matti Kankainen, Juuso Juhila, Anna Kanerva, Timo Joensuu, Siri Tähtinen, Akseli Hemminki

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number003490
JournalJournal for Immunotherapy of Cancer
Volume10
Issue number2
Number of pages15
ISSN2051-1426
DOIs
Publication statusPublished - Feb 2022
MoE publication typeA1 Journal article-refereed

Fields of Science

  • immunotherapy
  • oncolytic viruses
  • adaptive immunity
  • biomarkers
  • tumor
  • translational medical research
  • IN-VIVO
  • RESPONSES
  • PD-1
  • IMMUNOTHERAPY
  • DYSFUNCTION
  • PATHWAYS
  • IMMUNITY
  • 3122 Cancers

Cite this